EQIX
64
-5
SO
64
4
ITW
67
3
SJM
48
2
ED
55
3
WU
32
2
KLAC
63
-5
IPG
42
2
PCG
83
3
MCK
46
2
UAL
67
-2
NFLX
55
-2
AIV
68
-2
HCA
70
-3
ISRG
66
-2
QCOM
57
-2
GOOGL
58
2
BWA
56
3
NEM
42
-6
SRE
56
7
EQIX
64
-5
SO
64
4
ITW
67
3
SJM
48
2
ED
55
3
WU
32
2
KLAC
63
-5
IPG
42
2
PCG
83
3
MCK
46
2
UAL
67
-2
NFLX
55
-2
AIV
68
-2
HCA
70
-3
ISRG
66
-2
QCOM
57
-2
GOOGL
58
2
BWA
56
3
NEM
42
-6
SRE
56
7
Financhill
Back

Futu Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
30

FUTU
Futu Holdings

Last Price:
85.71
Seasonality Move:
2.94%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
30
Futu Holdings (FUTU) is a Sell

Is Futu Holdings a Buy, Sell or Hold?

  • The current Futu Holdings [FUTU] share price is $85.68. The Score for FUTU is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • FUTU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FUTU Stock Price Chart

What is Futu Holdings's stock price today?

  • The Futu Holdings share price today is $85.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FUTU is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

FUTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 79.24 Buy
Chaikin Money Flow: 4336755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.32 - 71.36) Buy
Bollinger Bands (100): (59.85 - 73.49) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

FUTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.21 Buy
20-day SMA: 64.55 Buy
50-day SMA: 62.12 Buy
200-day SMA: 60.36 Buy
8-day EMA: 74.22 Buy
20-day EMA: 67.59 Buy
50-day EMA: 64.61 Buy
200-day EMA: 61.5 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Futu Holdings Earnings Growth & FUTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.63 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Futu Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):